About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
AMRN
Recent Earnings
Amarin Non-GAAP EPS of $0.02 beats by $0.02, revenue of $90.25M beats by $1.07M
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Amarin Non-GAAP EPS of $0.02 beats by $0.02, revenue of $90.25M beats by $1.07M
- Hot Stocks: GOGO, PGNY surge on earnings news; AHCO drops; AMRN proxy fight
- Amarin Q4 2022 Earnings Preview
- Amarin 8% higher after Sarissa wins proxy battle with management
- Amarin inks licensing deal with CSL for heart drug Vazkepa in Australia, New Zealand
- Amarin tells shareholders to reject Sarissa proposals at upcoming meeting
- Amarin holders should vote against Sarissa board nominees, proxy advisor ISS says
- Amarin hits nine-month high amid proxy battle with Sarissa
- Amarin files proxy materials in battle with activist Sarissa
- Amarin's heart drug Vazkepa receives approval in New Zealand
- Amarin says it will announce special meeting after largest shareholder demands one
- Amarin wins positive views at Cantor on topline beat
- Amarin's largest shareholder wants special meeting to oust board chairman, add reps
- Amarin sees U.S. revenue stabilization amid generic thereat
- Amarin's heart drug Vazkepa gets approval in Switzerland
- Amarin wins regulatory nod in Australia for heart disease therapy
- Amarin adds 13% as independent study supports heart disease therapy
- Amarin posts Q3 beat, continues to suspend 2022 revenue guidance
- Amarin reports Q3 mixed earnings; continues to suspend 2022 revenue guidance
- Amarin Q3 2022 Earnings Preview
Recent Earnings
Amarin Non-GAAP EPS of $0.02 beats by $0.02, revenue of $90.25M beats by $1.07M
Date | Price | Open | High | Low | Vol | ER | |||
---|---|---|---|---|---|---|---|---|---|
Aug 3 | 1.270 | 1.320 |
1.405
|
1.240
|
4.93M | ||||
Aug 2 | 1.330 | 1.250 |
1.370
|
1.250
|
4.48M | ||||
Aug 1 | 1.290 | 1.320 |
1.350
|
1.270
|
4.27M | ||||
Jul 29 | 1.330 | 1.320 |
1.350
|
1.290
|
1.47M | ||||
Jul 28 | 1.340 | 1.350 |
1.365
|
1.280
|
681.89K | ||||
Jul 27 | 1.350 | 1.350 |
1.360
|
1.300
|
674.84K | ||||
Jul 26 | 1.330 | 1.310 |
1.375
|
1.300
|
813.97K | ||||
Jul 25 | 1.340 | 1.310 |
1.380
|
1.275
|
1.50M | ||||
Jul 22 | 1.280 | 1.340 |
1.340
|
1.260
|
6.13M | ||||
Jul 21 | 1.330 | 1.380 |
1.380
|
1.280
|
2.77M | ||||
Jul 20 | 1.340 | 1.290 |
1.410
|
1.260
|
2.74M | ||||
Jul 19 | 1.290 | 1.310 |
1.320
|
1.260
|
5.54M | ||||
Jul 18 | 1.290 | 1.380 |
1.390
|
1.260
|
2.71M | ||||
Jul 15 | 1.350 | 1.430 |
1.430
|
1.295
|
3.36M | ||||
Jul 14 | 1.420 | 1.390 |
1.430
|
1.365
|
2.43M | ||||
Jul 13 | 1.410 | 1.400 |
1.440
|
1.350
|
1.80M | ||||
Jul 12 | 1.400 | 1.390 |
1.450
|
1.290
|
5.34M | ||||
Jul 11 | 1.430 | 1.570 |
1.610
|
1.400
|
3.07M | ||||
Jul 8 | 1.620 | 1.550 |
1.630
|
1.510
|
1.16M | ||||
Jul 7 | 1.570 | 1.560 |
1.625
|
1.560
|
1.49M | ||||
Jul 6 | 1.560 | 1.550 |
1.645
|
1.530
|
2.77M | ||||
Jul 5 | 1.590 | 1.450 |
1.595
|
1.360
|
3.38M |